Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study

Given the COVID-19 pandemic, currently, there are many drugs in clinical trials against this virus. Among the excellent drug targets of SARS-CoV-2 are its proteases (Nsp3 and Nsp5) that plays vital role in polyprotein processing giving rise to functional nonstructural proteins, essential for viral r...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Biomol Struct Dyn
Hoofdauteurs: Kumar, Prateek, Bhardwaj, Taniya, Kumar, Ankur, Gehi, Bhuvaneshwari R., Kapuganti, Shivani K., Garg, Neha, Nath, Gopal, Giri, Rajanish
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Taylor & Francis 2020
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7678354/
https://ncbi.nlm.nih.gov/pubmed/33179586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1845976
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items